Product
Baloxavir Marboxil
Aliases
Xofluza
Name
Xofluza
INN Name
BALOXAVIR MARBOXIL
FDA Approved
Yes
5 clinical trials
1 organization
3 indications
1 document
Indication
InfluenzaIndication
Influenza AIndication
SARSClinical trial
A Multicenter, Single-Arm, Open-Label Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Otherwise Healthy Pediatric Patients From Birth to < 1 Year With Influenza-Like SymptomsStatus: Completed, Estimated PCD: 2023-04-03
Clinical trial
Evaluation of a Screen and Treat Protocol for Influenza in Socially Vulnerable Communities.Status: Not yet recruiting, Estimated PCD: 2024-05-31
Clinical trial
A Prospective, Multicenter, Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza AStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Randomized Double-blind, Placebo-controlled Single Center Pilot Study to Evaluate the Efficacy and Safety of Baloxavir in Combination With Oseltamivir in Adult Allogeneic Bone Marrow Transplant Recipients With InfluenzaStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
Randomised Evaluation of COVID-19 TherapyStatus: Recruiting, Estimated PCD: 2026-06-30
Document
DailyMed Label: XofluzaOrganization
A-S Medication Solutions